{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:48:37Z","timestamp":1790952517415,"version":"4.1.0"},"reference-count":151,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Recent discoveries demonstrated the skeleton\u2019s role as an endocrine organ regulating whole-body glucose homeostasis. Glucose metabolism is critical for rapid cell proliferation and tumour growth through increasing glucose uptake and fermentation of glucose to lactate despite being in an aerobic environment. This hypothesis paper discusses emerging evidence on how bones can regulate whole-body glucose homeostasis with potential to impact on tumour growth and proliferation. Moreover, it proposes a clinical link between bone glucose metabolism and prognosis of cancer based on recent clinical trial data. Targeting metabolic pathways related with classic glucose metabolism and also bone metabolism, novel methods of cancer therapy and treatment could be developed. This paper objective is to highlight the need for future research on this altered metabolism with potential to change future management of cancer patients.<\/jats:p>","DOI":"10.3389\/fonc.2024.1481241","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:11:01Z","timestamp":1731305461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?"],"prefix":"10.3389","volume":"14","author":[{"given":"Rucha","family":"Ronghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A. S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3109\/17453670903487040","article-title":"PET scanning for evaluation of bone metabolism","volume":"80","author":"Foldager","year":"2009","journal-title":"Acta orthopaedica"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct163","article-title":"Systems medicine: helping us understand the complexity of disease","volume":"106","author":"Vandamme","year":"2013","journal-title":"QJM: Int J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocrine practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084120","article-title":"Glucose metabolism in osteoblasts in healthy and pathophysiological conditions","volume":"22","author":"Donat","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.Epi-21-0842","article-title":"Cancer statistics over time in northwestern s\u00e3o paulo state, Brazil: incidence and mortality","volume":"31","author":"Mafra da Costa","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2309499020915989","article-title":"Incidence, prevalence, and outcomes of systemic Malignancy with bone metastases","volume":"28","author":"Jiang","year":"2020","journal-title":"J Orthopaedic Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12869","article-title":"Clinical utility of circulating tumor cells: an update","volume":"15","author":"Vasseur","year":"2021","journal-title":"Mol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1758834014521110","article-title":"Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies","volume":"6","author":"D'Antonio","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/jci43424","article-title":"Early tumor dissemination, but late metastasis: insights into tumor dormancy","volume":"120","author":"R\u00f6cken","year":"2010","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"15","author":"Yin","year":"2005","journal-title":"Cell Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022","article-title":"Survival after bone metastasis by primary cancer type: a Danish population-based cohort study","volume":"7","author":"Svensson","year":"2017","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of bone metastases in cancer: a review","volume":"56","author":"Selvaggi","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2016.03.007","article-title":"The role of osteoblasts in bone metastasis","volume":"5","author":"Ottewell","year":"2016","journal-title":"J Bone Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2007.09.021","article-title":"Metastatic breast cancer induces an osteoblast inflammatory response","volume":"314","author":"Kinder","year":"2008","journal-title":"Exp Cell Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060182","article-title":"Cancer metastases to bone: concepts, mechanisms, and interactions with bone osteoblasts","volume":"10","author":"Shupp","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of metastatic bone disease algorithms for diagnostics and treatment","volume":"36","author":"Jehn","year":"2016","journal-title":"Anticancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328356da72","article-title":"Glucose transporters in cancer metabolism","volume":"24","author":"Adekola","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060614-033904","article-title":"Transport of sugars","volume":"84","author":"Chen","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21885","article-title":"Kinetics of transport and phosphorylation of glucose in cancer cells","volume":"221","author":"Rodr\u00edguez-Enr\u00edquez","year":"2009","journal-title":"J\u00a0Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9750-1","article-title":"Citric acid cycle and role of its intermediates in metabolism","volume":"68","author":"Akram","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122161","article-title":"Rescue of TCA cycle dysfunction for cancer therapy","volume":"8","author":"Marquez","year":"2019","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01639-8","article-title":"The functional roles of TCA cycle metabolites in cancer","volume":"40","author":"Eniafe","year":"2021","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2011.07.003","article-title":"SDH mutations in cancer","volume":"1807","author":"Bardella","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201630","article-title":"Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma","volume":"14","author":"Ylisaukko-oja","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2858","article-title":"GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters","volume":"25","author":"Deng","year":"2016","journal-title":"Protein Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133374","article-title":"Glut 1 in cancer cells and the inhibitory action of resveratrol as A potential therapeutic strategy","volume":"20","author":"Zambrano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00712.2009","article-title":"Glucose transporters in the 21st century","volume":"298","author":"Thorens","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/147323001003800601","article-title":"Glucose transporter-1 as a new therapeutic target in\u00a0laryngeal carcinoma","volume":"38","author":"Luo","year":"2010","journal-title":"J Int Med Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322011000600008","article-title":"GLUT1 expression in Malignant tumors and its use as an immunodiagnostic marker","volume":"66","author":"Carvalho","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-27-34","article-title":"Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human Malignant melanomas and benign melanocytic lesions","volume":"27","author":"Parente","year":"2008","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5146\/tjpath.2021.01557","article-title":"GLUT-1 expression in breast cancer","volume":"38","author":"Okcu","year":"2022","journal-title":"Turk Patoloji Derg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23379","article-title":"Cellular distribution of Glut-1 and Glut-5 in benign and Malignant human prostate tissue","volume":"113","author":"Reinicke","year":"2012","journal-title":"J Cell Biochem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07238.x","article-title":"Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha","volume":"101","author":"Lidgren","year":"2008","journal-title":"BJU Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3892\/or.2010.1096","article-title":"Fructose transporter GLUT5 expression in clear renal cell carcinoma","volume":"25","author":"Medina Villaamil","year":"2011","journal-title":"Oncol Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3892\/mmr_00000300","article-title":"Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters","volume":"3","author":"Aparicio","year":"2010","journal-title":"Mol Med Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrm782","article-title":"Regulated transport of the glucose transporter GLUT4","volume":"3","author":"Bryant","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377846","article-title":"Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy","volume":"119","author":"McBrayer","year":"2012","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.728759","article-title":"Glucose metabolism and glucose transporters in breast cancer","volume":"9","author":"Shin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24698","article-title":"Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells","volume":"230","author":"Garrido","year":"2015","journal-title":"J Cell Physiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-05-3906","article-title":"Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms","volume":"66","author":"Tarn","year":"2006","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-08-0569","article-title":"A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death","volume":"7","author":"Wood","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Trans Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2017.03.009","article-title":"The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter","volume":"26","author":"Wu","year":"2018","journal-title":"J Food Drug Anal"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.3390\/cancers13164184","article-title":"Glucose transporters as a target for anticancer therapy","volume":"13","author":"Pliszka","year":"2021","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.Capr-08-0160","article-title":"Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials","volume":"2","author":"Bishayee","year":"2009","journal-title":"Cancer Prev Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1021\/bi001660j","article-title":"Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors","volume":"40","author":"Vera","year":"2001","journal-title":"Biochemistry"},{"key":"B58","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/0008-5472.Can-03-2404","article-title":"Resveratrol-induced autophagocytosis in ovarian cancer cells","volume":"64","author":"Opipari","year":"2004","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235811","article-title":"SGLT-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives","volume":"14","author":"Dutka","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110821","article-title":"Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK\/mTOR pathway","volume":"132","author":"Zhou","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/756134","article-title":"AKT kinase pathway: a leading target in cancer research","volume":"2013","author":"Kumar","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153314","article-title":"The pivotal role of MicroRNAs in glucose metabolism in cancer","volume":"217","author":"Taefehshokr","year":"2021","journal-title":"Pathol - Res Pract"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2009.12.006","article-title":"The role of p53 in glucose metabolism","volume":"22","author":"Cheung","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","journal-title":"Trends Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.05.027","article-title":"Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504","volume":"38","author":"Hu","year":"2010","journal-title":"Mol Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2174\/187231309788166398","article-title":"Chemical and biochemical basis of cell-bone matrix interaction in health and disease","volume":"3","author":"Feng","year":"2009","journal-title":"Curr Chem Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1615\/critreveukargeneexpr.v19.i3.10","article-title":"Osteoclasts have multiple roles in bone in addition to bone resorption","volume":"19","author":"Boyce","year":"2009","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/0169-6009(91)90039-3","article-title":"A reconstruction of the remodelling cycle in normal human cortical iliac bone","volume":"12","author":"Agerbaek","year":"1991","journal-title":"Bone Miner"},{"key":"B71","article-title":"Osteoblasts and bone formation","volume":"32","author":"Caetano-Lopes","year":"2007","journal-title":"Acta Reumatol Port"},{"key":"B72","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00003081-198712000-00004","article-title":"Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis","volume":"30","author":"Parfitt","year":"1987","journal-title":"Clin Obstetrics Gynecology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological bone remodeling: systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.063032","article-title":"Bone remodelling at a glance","volume":"124","author":"Crockett","year":"2011","journal-title":"J Cell Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-021-00149-x","article-title":"Skeletal endocrinology: where evolutionary advantage meets disease","volume":"9","author":"Jaschke","year":"2021","journal-title":"Bone Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008361","article-title":"An osteocalcin-deficient mouse strain without endocrine abnormalities","volume":"16","author":"Diegel","year":"2020","journal-title":"PloS Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.682947","article-title":"T cell protein tyrosine phosphatase in glucose metabolism. [Review","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J Bone Mineral Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-014-9931-y","article-title":"Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism","volume":"96","author":"Brennan-Speranza","year":"2015","journal-title":"Calcified Tissue Int"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jor.22288","article-title":"Effects of local insulin delivery on subperiosteal angiogenesis and mineralized tissue formation during fracture healing","volume":"31","author":"Paglia","year":"2013","journal-title":"J Orthopaedic Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyss\u00e9gur","year":"2006","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.25","article-title":"Role of bone in glucose metabolism","volume":"14","author":"Greenhill","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1172\/jci97794","article-title":"Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism","volume":"128","author":"Dirckx","year":"2018","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"E992","DOI":"10.1073\/pnas.1718009115","article-title":"HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice","volume":"115","author":"Devignes","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2023.100473","article-title":"Hypoxia signaling in bone physiology and energy metabolism","volume":"32","author":"Valle-Tenney","year":"2023","journal-title":"Curr Opin Endocrine Metab Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvv124","article-title":"Regulation of bone metabolism by Wnt signals","volume":"159","author":"Kobayashi","year":"2016","journal-title":"J Biochem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1155","article-title":"GSK-3\u03b2 Function in bone regulates skeletal development, whole-body metabolism, and male life span","volume":"154","author":"Gillespie","year":"2013","journal-title":"Endocrinology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.01.028","article-title":"Wnt\/\u03b2-catenin signaling in osteoblasts regulates global energy metabolism","volume":"97","author":"Yao","year":"2017","journal-title":"Bone"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00657","article-title":"Lack of lrp5 signaling in osteoblasts sensitizes male mice to diet-induced disturbances in glucose metabolism","volume":"158","author":"Kim","year":"2017","journal-title":"Endocrinology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1642","article-title":"DLK1 regulates whole-body glucose metabolism: A negative feedback regulation of the osteocalcin-insulin loop","volume":"64","author":"Abdallah","year":"2015","journal-title":"Diabetes"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/biom12111674","article-title":"Osteoglycin: an ECM factor regulating fibrosis and tumorigenesis","volume":"12","author":"Nulali","year":"2022","journal-title":"Biomolecules"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2014.12.010","article-title":"NPY signalling in early osteoblasts controls glucose homeostasis","volume":"4","author":"Lee","year":"2015","journal-title":"Mol Metab"},{"key":"B101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmet.2018.05.004","article-title":"Osteoglycin, a novel coordinator of bone and glucose homeostasis","volume":"13","author":"Lee","year":"2018","journal-title":"Mol Metab"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0036-y","article-title":"Osteoglycin \u2014 linking bone and energy homeostasis","volume":"14","author":"Leong","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4158\/ep12141.Ra","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocr Pract"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","article-title":"Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism","volume":"64","author":"Park","year":"2015","journal-title":"Metabolism"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","article-title":"Tissue-specific effects of leptin on glucose and lipid metabolism","volume":"42","author":"Pereira","year":"2020","journal-title":"Endocrine Rev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.05.046","article-title":"New insights into the biology of osteocalcin","volume":"82","author":"Zoch","year":"2016","journal-title":"Bone"},{"key":"B108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-nutr-061121-091348","article-title":"Osteocalcin: A multifaceted bone-derived hormone","volume":"43","author":"Karsenty","year":"2023","journal-title":"Annu Rev Nutr"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.292193","article-title":"Role of osteoglycin in the linkage between muscle and bone","volume":"287","author":"Tanaka","year":"2012","journal-title":"J Biol Chem"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.03.017","article-title":"WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation","volume":"17","author":"Esen","year":"2013","journal-title":"Cell Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4781(02)00245-2","article-title":"Analysis of the promoter region of human mimecan gene","volume":"1575","author":"Tasheva","year":"2002","journal-title":"Biochim Biophys Acta (BBA) - Gene Structure Expression"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3181\/0701-rm-8","article-title":"Differential expression of mimecan and thioredoxin domain\u2013containing protein 5 in colorectal adenoma and cancer: A proteomic study","volume":"232","author":"Wang","year":"2007","journal-title":"Exp Biol Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S222967","article-title":"Osteoglycin (OGN) inhibits cell proliferation and invasiveness in breast cancer via PI3K\/akt\/mTOR signaling pathway","volume":"12","author":"Xu","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ebiom.2018.07.021","article-title":"Osteoglycin-induced VEGF inhibition enhances T lymphocytes infiltrating in colorectal cancer","volume":"34","author":"Hu","year":"2018","journal-title":"EBioMedicine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"124ra127","DOI":"10.1126\/scitranslmed.3003293","article-title":"Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy","volume":"4","author":"Lee","year":"2012","journal-title":"Sci Transl Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1202-y","article-title":"Preclinical evaluation of a novel triple-acting PIM\/PI3K\/mTOR inhibitor, IBL-302, in breast cancer","volume":"39","author":"Kennedy","year":"2020","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.5120","article-title":"Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter\u22121 and","volume":"57","author":"Xu","year":"2020","journal-title":"Int J Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S200059","article-title":"The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"Bmj"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.06.038","article-title":"Use of metformin and the risk of ovarian cancer: A case\u2013control analysis","volume":"123","author":"Bodmer","year":"2011","journal-title":"Gynecologic Oncol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.01.007","article-title":"Effects of metformin on head and neck cancer: a systematic review","volume":"51","author":"R\u00eago","year":"2015","journal-title":"Oral Oncol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent Malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Investigational New Drugs"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.73.4491","article-title":"Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes","volume":"35","author":"Wu","year":"2017","journal-title":"J Clin Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.2337\/dcS13-2002","article-title":"Insulin therapy and cancer","volume":"36","author":"Home","year":"2013","journal-title":"Diabetes Care"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-07-4749","article-title":"Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse","volume":"14","author":"Bidard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1177\/1758834011412656","article-title":"Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion","volume":"3","author":"Steger","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"B130","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ctrv.2007.09.002","article-title":"RANK ligand as a therapeutic target for bone metastases and multiple myeloma","volume":"34","author":"Roodman","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.588095","article-title":"Efficacy and safety of denosumab in osteoporosis or low bone mineral density postmenopausal women. [Systematic review","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30862-3","article-title":"Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Gnant","year":"2019","journal-title":"Lancet Oncol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/21556660.2021.1989194","article-title":"Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis","volume":"10","author":"Pacheco-Soto","year":"2021","journal-title":"J Drug Assess"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.06.005","article-title":"Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength","volume":"5","author":"Kostenuik","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8724869","article-title":"Serum osteoprotegerin is a potential biomarker of insulin resistance in chinese postmenopausal women with prediabetes and type 2 diabetes","volume":"2017","author":"Duan","year":"2017","journal-title":"Int J Endocrinol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-015-0140-6","article-title":"Q&A: insulin secretion and type 2 diabetes: why do \u03b2-cells fail","volume":"13","author":"Cantley","year":"2015","journal-title":"BMC Biol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1172\/jci125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-030-50224-9_3","article-title":"The non-bone-related role of RANK\/RANKL signaling in cancer","volume":"1277","author":"van Dam","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2017.11.001","article-title":"RANKL and RANK: from mammalian physiology to cancer treatment","volume":"28","author":"Rao","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-018-1641-x","article-title":"Selective inhibition of receptor activator of NF-\u03baB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction","volume":"96","author":"Slavic","year":"2018","journal-title":"J Mol Med (Berl)"},{"key":"B146","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2016.03.013","article-title":"Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury","volume":"94","author":"Carbone","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B148","doi-asserted-by":"publisher","first-page":"17019","DOI":"10.1038\/boneres.2017.19","article-title":"RANKL-induced M1 macrophages are involved in bone formation","volume":"5","author":"Huang","year":"2017","journal-title":"Bone Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2012.03.010","article-title":"Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa\u00a0B ligand\/osteoprotegerin","volume":"38","author":"Liu","year":"2012","journal-title":"J Endod"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J Cell Biochem"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1481241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:11:06Z","timestamp":1731305466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1481241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":151,"alternative-id":["10.3389\/fonc.2024.1481241"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1481241","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"article-number":"1481241"}}